MY126520A - A reinforced immunogen for an inactivated vaccine against infectious disease caused by the group of japanese encephalitis virus and a method for producing the same - Google Patents
A reinforced immunogen for an inactivated vaccine against infectious disease caused by the group of japanese encephalitis virus and a method for producing the sameInfo
- Publication number
- MY126520A MY126520A MYPI99002242A MYPI19992242A MY126520A MY 126520 A MY126520 A MY 126520A MY PI99002242 A MYPI99002242 A MY PI99002242A MY PI19992242 A MYPI19992242 A MY PI19992242A MY 126520 A MY126520 A MY 126520A
- Authority
- MY
- Malaysia
- Prior art keywords
- reinforced
- immunogen
- producing
- group
- same
- Prior art date
Links
- 241000710842 Japanese encephalitis virus Species 0.000 title abstract 2
- 230000002163 immunogen Effects 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 208000035473 Communicable disease Diseases 0.000 title 1
- 229940031551 inactivated vaccine Drugs 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 229940028617 conventional vaccine Drugs 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/06—Inactivation or attenuation by chemical treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
- C12N2770/24163—Methods of inactivation or attenuation by chemical treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31976298 | 1998-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY126520A true MY126520A (en) | 2006-10-31 |
Family
ID=18113906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI99002242A MY126520A (en) | 1998-10-05 | 1999-06-03 | A reinforced immunogen for an inactivated vaccine against infectious disease caused by the group of japanese encephalitis virus and a method for producing the same |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6841374B1 (https=) |
| EP (1) | EP1057889B1 (https=) |
| JP (2) | JP4371343B2 (https=) |
| KR (1) | KR20010032699A (https=) |
| CN (2) | CN1160454C (https=) |
| AU (1) | AU743546B2 (https=) |
| CA (1) | CA2311336C (https=) |
| MY (1) | MY126520A (https=) |
| TW (1) | TWI227274B (https=) |
| WO (1) | WO2000020565A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10144906B4 (de) * | 2001-09-12 | 2013-11-28 | Novartis Vaccines And Diagnostics Gmbh | Verfahren zur großtechnischen Herstellung von Impfstoffen |
| US7060280B2 (en) * | 2003-06-11 | 2006-06-13 | Academia Sinica | Immunization against flavivirus |
| US7780027B2 (en) * | 2007-02-08 | 2010-08-24 | Michael Coady | Axially stacked double barrel animal feeder system |
| EP2192917B1 (en) * | 2007-08-28 | 2014-01-29 | Baxter International Inc. | Method for producing viral vaccines |
| CA2710611C (en) * | 2007-12-26 | 2016-12-20 | The Kitasato Institute | Method of producing japanese encephalitis vaccine stably storable over long time and use of the vaccine |
| KR101507822B1 (ko) | 2008-06-04 | 2015-04-24 | 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 | 불활성화 일본 뇌염 바이러스 입자를 어쥬번트로서 사용하는 방법 |
| CN101333246B (zh) * | 2008-07-30 | 2011-04-13 | 中国农业科学院哈尔滨兽医研究所 | 乙型脑炎病毒e蛋白中和性b细胞抗原表位多肽及其应用 |
| EP2358733B1 (en) * | 2008-11-17 | 2015-07-08 | Inovio Pharmaceuticals, Inc. | Antigens that elicit immune response against flavivirus and methods of using same |
| KR20120027381A (ko) * | 2009-05-25 | 2012-03-21 | 파나세아 바이오테크 리미티드 | 일본뇌염 백신 및 그것의 제조 방법 |
| CN101792741A (zh) * | 2010-04-07 | 2010-08-04 | 西北农林科技大学 | 表达jev免疫原基因的重组杆状病毒及其制备和应用 |
| JP6963460B2 (ja) * | 2016-10-27 | 2021-11-10 | 一般財団法人阪大微生物病研究会 | たん白質の定量方法 |
| WO2021161390A1 (ja) * | 2020-02-10 | 2021-08-19 | 花王株式会社 | ヒトノロウイルス不活化評価法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6147185A (ja) * | 1984-08-09 | 1986-03-07 | Chemo Sero Therapeut Res Inst | 日本脳炎ウイルスの精製方法 |
| JPS6153227A (ja) | 1984-08-23 | 1986-03-17 | Biseibutsu Kagaku Kenkyusho:Kk | 日本脳炎・豚パルボウイルス感染症混合生ワクチン |
| US5719051A (en) * | 1989-12-22 | 1998-02-17 | Immuno Aktiengesellschaft | Perfusion system and a method for the large scale production of virus or virus antigen |
| AT393356B (de) * | 1989-12-22 | 1991-10-10 | Immuno Ag | Verfahren zur herstellung von fsme-virus-antigen |
| JPH07265093A (ja) * | 1994-03-30 | 1995-10-17 | Chemo Sero Therapeut Res Inst | 哺乳動物細胞を用いる日本脳炎ウイルス表面抗原蛋白質の製法 |
| CN1122531C (zh) | 1995-08-01 | 2003-10-01 | 巴斯德梅诺血清和疫苗公司 | 抗日本脑炎疫苗的工业生产方法和所获得的疫苗 |
| US6207439B1 (en) * | 1997-03-25 | 2001-03-27 | Center For Disease Control | Purification of Japanese encephalitis virus |
| US5891705A (en) | 1997-04-08 | 1999-04-06 | Pentose Pharmaceuticals, Inc. | Method for inactivating a virus |
| DK1025209T3 (da) | 1997-08-28 | 2007-06-25 | Cheil Jedang Corp | Et attenueret japansk encephalitis-virus tilpasset til Vero-celle og en japansk encephalitis-vaccine |
-
1999
- 1999-06-02 KR KR1020007005984A patent/KR20010032699A/ko not_active Ceased
- 1999-06-02 EP EP99923858A patent/EP1057889B1/en not_active Expired - Lifetime
- 1999-06-02 CN CNB998017647A patent/CN1160454C/zh not_active Expired - Fee Related
- 1999-06-02 TW TW88109144A patent/TWI227274B/zh not_active IP Right Cessation
- 1999-06-02 WO PCT/JP1999/002931 patent/WO2000020565A1/ja not_active Ceased
- 1999-06-02 CA CA 2311336 patent/CA2311336C/en not_active Expired - Fee Related
- 1999-06-02 US US09/555,704 patent/US6841374B1/en not_active Expired - Fee Related
- 1999-06-02 AU AU40578/99A patent/AU743546B2/en not_active Ceased
- 1999-06-02 JP JP2000574663A patent/JP4371343B2/ja not_active Expired - Lifetime
- 1999-06-02 CN CNA2004100473162A patent/CN1618464A/zh active Pending
- 1999-06-03 MY MYPI99002242A patent/MY126520A/en unknown
-
2009
- 2009-07-08 JP JP2009162261A patent/JP5095685B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2311336A1 (en) | 2000-04-13 |
| CN1618464A (zh) | 2005-05-25 |
| EP1057889B1 (en) | 2009-04-22 |
| AU743546B2 (en) | 2002-01-31 |
| AU4057899A (en) | 2000-04-26 |
| WO2000020565A1 (en) | 2000-04-13 |
| EP1057889A1 (en) | 2000-12-06 |
| JP4371343B2 (ja) | 2009-11-25 |
| CN1160454C (zh) | 2004-08-04 |
| CA2311336C (en) | 2007-01-02 |
| JP2009225809A (ja) | 2009-10-08 |
| CN1287573A (zh) | 2001-03-14 |
| US6841374B1 (en) | 2005-01-11 |
| EP1057889A4 (en) | 2002-01-23 |
| JP5095685B2 (ja) | 2012-12-12 |
| TWI227274B (en) | 2005-02-01 |
| KR20010032699A (ko) | 2001-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY126520A (en) | A reinforced immunogen for an inactivated vaccine against infectious disease caused by the group of japanese encephalitis virus and a method for producing the same | |
| LU91314I2 (fr) | "Combinaison de particules viroides de papillomavirus humain de type 6, 11, 16 et 18 (GARDASIL -GilGARD )" | |
| GR3035712T3 (en) | European vaccine strains of the porcine reproductive and respiratory syndrome virus (PRRSV) | |
| TW289050B (https=) | ||
| AU4324996A (en) | Novel cyclodextrin-derivatives and methods for the preparation thereof | |
| ZA978865B (en) | Reshaped human anti-HM 1.24 antibody. | |
| KR930703362A (ko) | 병원체로부터 얻은 항원성 폴리오사이드로부터 유도된 올리고사이드 | |
| EA199700413A1 (ru) | Композиция, содержащая вакцину и конъюгат антигена и полисахарида, адсорбированные на фосфате алюминия | |
| BR9608535A (pt) | Agente virulento associado com a doença de suínos ignorada | |
| RU97101084A (ru) | Штамм streptococcus equi, микробиологически чистая культура, живая вакцина и способ ее получения | |
| GR3035135T3 (en) | Poultry vaccine containing infections bronchitis virus serotype 4/91. | |
| ES533111A0 (es) | Un metodo de preparar una vacuna viva | |
| WO1994006913A3 (en) | Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines | |
| IL95867A0 (https=) | ||
| BG102809A (en) | Vaccine against the reproductive and respiratory syndrome in pigs | |
| EP1013757A3 (en) | Attenuated forms of bovine viral diarrhea virus | |
| ATE518879T1 (de) | Verfahren zur herstellung eines partiellen orf2 proteins des hepatitis e virus | |
| HU906509D0 (en) | Process for producing vaccine against virus of infecting bronchitis | |
| EP0750669A4 (en) | CHANGED L2-PROTEIN OF THE PAPILLOMAVIRUS AND PRESENT VIROID | |
| AU3115189A (en) | Live combination vaccine | |
| ZA964094B (en) | Compositions and methods for the diagnosis of and vaccination against hepatitis c virus (hcv) | |
| CA2015828A1 (en) | Canine corona virus vaccine | |
| PL346195A1 (en) | Chicken anaemia virus (cav) of weakened patogenicity, vaccine for protecting poultry against cav and method of obtaining cav of weakened pathogenicity | |
| AU4952393A (en) | New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate | |
| BR9711138A (pt) | Prepara-{es de herperv¡rus equino com prote-Æo mÚtua e m-todo de fazer e usar as mesmas |